Maya Beganovic

Infectious diseases/ Anti-infective Pharmacovigilance PharmD for FDA CDER OSE DPV. Views are my own.

[Maya Beganovic @MayaBeganovic1]

@KelliePharmD @jendel0717 @lachance_erik @MAndersonIDRx 🥰 I miss working with you. Happy #IDPharmacistsDay to you too!

[Maya Beganovic @MayaBeganovic1]

@ElleElleAre Color ✅ sparkle ✅ texture ✅. I'm not seeing the problem here 😜😉.

[Maya Beganovic @MayaBeganovic1]

@AmandaMiceli3 @LurieChildrens Congratulations 👏👏👏

[Maya Beganovic @MayaBeganovic1]

@ElleElleAre @EmilyMGates @rondapeds_ID @KelliePharmD This is brilliant!!! 🤣

[Maya Beganovic @MayaBeganovic1]

@TheIDApprentice I am so sorry for your loss, Eric.

[Maya Beganovic @MayaBeganovic1]

@ElleElleAre Congratulations 👏👏👏

[IDSA @IDSAInfo]

New case series in OFID: Among patients hospitalized with #COVID19 at two NYC hospitals, secondary S. aureus bacteremia was uncommon but associated with high mortality.

📄: https://t.co/yhvNnXnMaV

#OpenForumInfectDis #IDSAJournals @PaulSaxMD @jackiecusumano

[Maya Beganovic @MayaBeganovic1]

@rondapeds_ID Happy #AntibioticAwarenessWeek ❤️ always my favorite time of year!

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

NEW🔥🔥 #ofid @lindsay_petty
Assessment of Testing and Treatment of ASB in ED
Of 2461 patients with ASB, 74.4% received antibiotics. EM clinicians ordered urine cultures in 80.0% of patients and initiated treatment in 68.5%. #IDTwitter @TGandhi_Safety https://t.co/4mmwFrPHh5

[Maya Beganovic @MayaBeganovic1]

@Steph_lnfection @IDWeek2020 I miss those days. We lived off of starbucks kiosks and pre-presentation 🐨 viewing.

[Eric Wenzler @TheIDApprentice]

Would have loved to see presence/lack of an ASP and/or RDTs as a covariate in this. Regardless, more evidence that TTET is driver of mortality, not resistance

@lodise_tom

https://t.co/WNWby1dt5r

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

NEW 🔥 #ACC @ASMicrobiology @TheIDApprentice
Avibactam restored aztreonam susceptibility in 98% of aztreonam-resistant Stenotrophomonas maltophilia isolates,compared to 61%, 71%, and 15% with clavulanate,relebactam& vaborbactam,respectively #IDTwitter
https://t.co/NMBtOTy1fR

[Erin McCreary @ErinMcCreary]

Congratulations @pranita_tamma @OncIDPharmd @davidvanduin @ClancyNeil and #twitterless Drs. Mathers and Bonomo on publishing the @IDSAInfo Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections!!
https://t.co/SAsO0mjee9

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🌟β-lactam Dosing Strategies: Think before You Push.🌟
Simulations demonstrated that IV Push cefepime resulted in lower PTAs than traditional intermittent infusion among a subset of elevated MICs. #IDTwitter #IJAA https://t.co/fuNkZkybxH

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥Interesting🔥 @PharmacoJournal @KellyReveles
National Trends in Oral Antibiotic Prescribing in US Physician Offices 2009-2016
No significant ⬇️ in outpatient Abx prescribing
>50% of ABx inappropriate
The most common Abx class was❓🤔#IDtwitter https://t.co/JjH5oMmXAY

[Maya Beganovic @MayaBeganovic1]

@ConanMacDougall @KelliePharmD @jendel0717 @MAndersonIDRx @lachance_erik "Spectrum insurance"- great way of putting it! We often educate on resistance mechanisms during stewardship rounds but it's a common misconception that clav adds "something" for strep, or that amox alone is perceived as not enough/ "wimpy".

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Interesting! #AAC
Oral step-down therapy for uncomplicated streptococcal BSI with a BL is non-inferior to a FQ.
@MayaBeganovic1 #IDTwitter @ASMicrobiology
https://t.co/7HitAblPKH

[Maya Beganovic @MayaBeganovic1]

@JayCdoesID Thank you ☺️

[Maya Beganovic @MayaBeganovic1]

@Steph_lnfection Thank you Steph 😊 Already looking forward to our outings 😂